ProfileGDS4718 / 244276_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 70% 36% 53% 63% 45% 38% 74% 55% 58% 68% 48% 72% 38% 42% 74% 64% 35% 43% 41% 46% 69% 74% 43% 72% 38% 61% 43% 54% 34% 52% 44% 67% 69% 40% 35% 40% 54% 65% 41% 58% 37% 43% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4465
GSM549102patient 115, normal, homogenized [OPG study]6.8088670
GSM549104patient 119, normal, homogenized [OPG study]4.7780236
GSM549108patient 138, normal, homogenized [OPG study]5.7426953
GSM549119patient 077, normal, homogenized [OPG study]6.3079163
GSM549133patient 032, cancer, homogenized [OPG study]5.1799645
GSM549139patient 042, cancer, homogenized [OPG study]4.8729338
GSM549099patient 107, normal, homogenized [OPG study]7.1813374
GSM549109patient 139, normal, homogenized [OPG study]5.8539955
GSM549110patient 046, normal, homogenized [OPG study]5.9947158
GSM549114patient 063, normal, homogenized [OPG study]6.648568
GSM549122patient 082, normal, homogenized [OPG study]5.4085748
GSM549134patient 033, cancer, homogenized [OPG study]7.0566672
GSM549136patient 036, cancer, homogenized [OPG study]4.8455938
GSM549140patient 044, cancer, homogenized [OPG study]5.0637442
GSM549111patient 047, normal, homogenized [OPG study]7.2887474
GSM549113patient 057, normal, homogenized [OPG study]6.4006464
GSM549132patient 031, cancer, homogenized [OPG study]4.7504535
GSM549137patient 038, cancer, homogenized [OPG study]5.1173643
GSM549142patient 047, cancer, homogenized [OPG study]5.1503341
GSM549100patient 110, normal, homogenized [OPG study]5.3199646
GSM549107patient 135, normal, homogenized [OPG study]6.810669
GSM549115patient 068, normal, homogenized [OPG study]7.3300174
GSM549116patient 072, normal, homogenized [OPG study]5.1102143
GSM549120patient 078, normal, homogenized [OPG study]7.0478972
GSM549131patient 030, cancer, homogenized [OPG study]4.8594338
GSM549118patient 074, normal, homogenized [OPG study]6.1972761
GSM549129patient 027, cancer, homogenized [OPG study]5.1361543
GSM549123patient 088, normal, homogenized [OPG study]5.7645754
GSM549124patient 006, cancer, homogenized [OPG study]4.7709234
GSM549126patient 015, cancer, homogenized [OPG study]5.619652
GSM549128patient 025, cancer, homogenized [OPG study]5.1609344
GSM549103patient 117, normal, homogenized [OPG study]6.5879167
GSM549117patient 073, normal, homogenized [OPG study]6.6950369
GSM549138patient 041, cancer, homogenized [OPG study]4.978840
GSM549141patient 045, cancer, homogenized [OPG study]4.6929735
GSM549130patient 028, cancer, homogenized [OPG study]4.9740540
GSM549101patient 111, normal, homogenized [OPG study]5.7449254
GSM549105patient 128, normal, homogenized [OPG study]6.4576665
GSM549106patient 134, normal, homogenized [OPG study]4.980841
GSM549112patient 048, normal, homogenized [OPG study]5.9514458
GSM549125patient 011, cancer, homogenized [OPG study]4.840437
GSM549127patient 024, cancer, homogenized [OPG study]5.1172343
GSM549135patient 035, cancer, homogenized [OPG study]4.8192537